Abstract:Background: In humans, imaging of tumors provides rapid, accurate assessment of tumor growth and location. In laboratory animals, however, the imaging of spontaneously occurring tumors continues to pose many technical and logistical problems. Recently a mouse model was generated in which a chimeric protein consisting of HIF-1 alpha oxygen-dependent degradation domain (ODD) fused to luciferase was ubiquitously expressed in all tissues. Hypoxic stress leads to the accumulation of ODD-luciferase in the tissues of this mouse model which can be identified by non-invasive bioluminescence measurement. Since solid tumors often contain hypoxic regions, we performed proof-of-principle experiments testing whether this transgenic mouse model may be used as a universal platform for non-invasive imaging analysis of spontaneous solid tumors.Methods and Materials: ODD-luciferase transgenic mice were bred with MMTV-neu/beclin1+/- mice. Upon injection of luciferin, bioluminescent background of normal tissues in the transgenic mice and bioluminescent signals from spontaneously mammary carcinomas were measured non-invasively with an IVIS Spectrum imaging station. Tumor volumes were measured manually and the histology of tumor tissues was analyzed.Conclusion: Our results show that spontaneous mammary tumors in ODD-luciferase transgenic mice generate substantial bioluminescent signals, which are clearly discernable from background tissue luminescence. Moreover, we demonstrate a strong quantitative correlation between the bioluminescent tumor contour and the volume of palpable tumors. We further demonstrate that shrinkage of the volume of spontaneous tumors in response to chemotherapeutic treatment can be determined quantitatively using this system. Finally, we show that the growth and development of spontaneous tumors can be monitored longitudinally over several weeks. Thus, our results suggest that this model could potentially provide a practical, reliable, and cost-effective non-invasive quantitative method for imaging spontaneous solid tumors in mice.

Novel Bioluminescent Activatable Reporter for Src Tyrosine Kinase Activity in Living Mice

Early Tumor Detection Afforded by in Vivo Imaging of Near-Infrared Ii Fluorescence

Novel Split-Luciferase-Based Genetically Encoded Biosensors for Noninvasive Visualization of Rho GTPases

Molecular Imaging of Tumor Angiogenesis and Therapeutic Effects with Dual Bioluminescence

Noninvasive Imaging of Ras Activity by Monomolecular Biosensor Based on Split-Luciferase Complementary Assay

Noninvasive Molecular Imaging Of C-Myc Activation In Living Mice

Bioluminescent reporter gene for monitoring DNA (Deoxyribonucleic Acid) synthesis phase and application thereof

Bioluminescence Imaging of DNA Synthetic Phase of Cell Cycle in Living Animals

Fluorophore-NanoLuc BRET Reporters Enable Sensitive in Vivo Optical Imaging and Flow Cytometry for Monitoring Tumorigenesis.

A bioluminescence reporter mouse strain for in vivo imaging of CD8+ T cell localization and function

A luciferase prosubstrate and a red bioluminescent calcium indicator for imaging neuronal activity in mice

Use Of The Odd-Luciferase Transgene For The Non-Invasive Imaging Of Spontaneous Tumors In Mice

Targeted Bioluminescent Imaging of Pancreatic Ductal Adenocarcinoma Using Nanocarrier-Complexed EGFR-Binding Affibody–Gaussia Luciferase Fusion Protein

Optimized in vivo multispectral bioluminescent imaging of tumor biology using engineered BRET reporters

In vivo bioluminescence imaging of furin activity in breast cancer cells using bioluminogenic substrates.

Non-Invasive Direct Visualization of Luciferase-Luciferin Emitted Light Producing True Images from an Orthotopic Lung Cancer Xenograft Model in Nude Mice Using an Ultra-sensitive Low-light Camera and Optics

Novel NanoLuc substrates enable bright two-population bioluminescence imaging in animals

Development of two mouse strains conditionally expressing bright luciferases with distinct emission spectra as new tools for in vivo imaging

A new bioluminescent reporter system to study the biodistribution of systematically injected tumor-derived bioluminescent extracellular vesicles in mice

Combined Bioluminescence and Fluorescence Imaging Visualizing Orthotopic Lung Adenocarcinoma Xenograft in Vivo.

ATP-Independent Bioluminescent Reporter Variants To Improve in Vivo Imaging